ConductScience.org, home

Trial · NCT07513870

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDepth of Anesthesia Assessed by Bispectral Index (BIS)During surgery (at 1, 2, 5, 10, 20, 30, 40 minutes and at the end of surgery)
Anesthesia depth was monitored continuously using a four-channel frontal pEEG electrode to maintain a target BIS value between 40 and 55. The Bispectral Index scale ranges from a minimum of 0 to a maximum of 100. Lower scores indicate deeper sedation/anesthesia, while higher scores indicate a more awake state
PrimaryNeonatal Neurologic and Adaptive Capacity Score (NACS)At 1 minute, 1 hour, and 24 hours post-delivery
The Neonatal Neurologic and Adaptive Capacity Score (NACS) is a neurobehavioral assessment scale for newborns. The scale ranges from a minimum score of 0 to a maximum score of 40. Higher scores indicate a better outcome (better neurological adaptation). Scores of 35 or above indicate normal/adequate neurological adaptation, while scores below 35 indicate inadequate adaptation
SecondaryUmbilical Cord Arterial pHwithin the first 5 minutes after deliveryAnalysis of umbilical cord blood evaluating pH, to assess the newborn's immediate postnatal transition and metabolic state.
SecondaryUmbilical Cord Arterial pco2Within the first 5 minutes after deliveryAnalysis of umbilical cord blood evaluating PCO2, to assess the newborn's immediate postnatal transition and metabolic state.
SecondaryUmbilical Cord Arterial po2Within the first 5 minutes after deliveryAnalysis of umbilical cord blood evaluating PO2, to assess the newborn's immediate postnatal transition and metabolic state.
SecondaryUmbilical Cord total hemoglobinWithin the first 5 minutes after deliveryAnalysis of umbilical cord blood evaluating total hemoglobin, to assess the newborn's immediate postnatal transition and metabolic state.
SecondaryUmbilical Cord glucose levelsWithin the first 5 minutes after deliveryAnalysis of umbilical cord blood evaluating glucose levels, to assess the newborn's immediate postnatal transition and metabolic state
SecondaryMaternal Systolic Blood Pressure (Unit: mmHg)Intraoperative (Recorded from induction to the end of the operation)Continuous monitoring of systolic arterial blood pressures to assess maternal cardiovascular stability.
SecondaryMaternal diastolic Blood Pressure (Unit: mmHg)Intraoperative (Recorded from induction to the end of the operation)Continuous monitoring of diastolic arterial blood pressures, to assess maternal cardiovascular stability.
SecondaryMaternal mean Blood Pressure (Unit: mmHg)Intraoperative (Recorded from induction to the end of the operation)Continuous monitoring of mean arterial blood pressures, to assess maternal cardiovascular stability.
SecondaryMaternal Heart RateIntraoperative (Recorded from induction to the end of the operation)Continuous monitoring of heart rate to assess maternal cardiovascular stability.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07513870/registered